Thomas Areschoug
Corporate Officer/Principal at XINTELA AB
Thomas Areschoug active positions
| Companies | Position | Start | End |
|---|---|---|---|
| XINTELA AB | Corporate Officer/Principal | 2017-02-28 | - |
Career history of Thomas Areschoug
Former positions of Thomas Areschoug
| Companies | Position | Start | End |
|---|---|---|---|
Invest in Skane AB
 Invest in Skane AB Miscellaneous Commercial ServicesCommercial Services Invest in Skane AB provides organization consulting services. The private company is based in Skane, Sweden. | Corporate Officer/Principal | - | - |
Minervax ApS
 Minervax ApS Medical SpecialtiesHealth Technology Minervax ApS provides vaccine against streptococci. It utilizes fusion protein, which has proved to elicit good protective immunity. Its vaccine provides protective immunity against many clinically relevant GBS strains. The firm is engages in biotechnology, scientific and technical activities, and research and development. The company was founded in 2010 and is headquartered in Copenhagen, Denmark. | Director/Board Member | 2009-12-31 | - |
| Founder | 2009-12-31 | - |
Statistics
International
| Sweden | 3 |
| Denmark | 2 |
Operational
| Corporate Officer/Principal | 2 |
| Director/Board Member | 1 |
| Founder | 1 |
Sectoral
| Health Technology | 3 |
| Commercial Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| XINTELA AB | Health Technology |
| Private companies | 2 |
|---|---|
Invest in Skane AB
Invest in Skane AB Miscellaneous Commercial ServicesCommercial Services Invest in Skane AB provides organization consulting services. The private company is based in Skane, Sweden. | Commercial Services |
Minervax ApS
Minervax ApS Medical SpecialtiesHealth Technology Minervax ApS provides vaccine against streptococci. It utilizes fusion protein, which has proved to elicit good protective immunity. Its vaccine provides protective immunity against many clinically relevant GBS strains. The firm is engages in biotechnology, scientific and technical activities, and research and development. The company was founded in 2010 and is headquartered in Copenhagen, Denmark. | Health Technology |
- Stock Market
- Insiders
- Thomas Areschoug
- Experience
